SEC Form 3 · accession 0001567619-18-004311
Avalo Therapeutics, Inc. · AVTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
May 15, 2018
Accepted (ET)
Oct 18, 2018 · 5:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001534120
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 3,767,442 | I | By LRS International, Inc. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1LRS International, LLC ("LRS") is the record holder of the securities. Robert Moscato is the founder and principal of LRS and may be deemed to beneficially own the securities held by LRS. The Reporting Persons disclaim beneficial ownership of the securities except to the extent of their pecuniary interest therein.